LATEST DEVELOPMENTS

10/12/12

BigDNA awarded part of €6 million European project to develop new fish vaccines

Click here to read more

01/08/12

BigDNA awarded SMART innovation grant from Scottish Enterprise

Click here to read more

07/12/11

Drs Russell Greig and Alex Chanas join BigDNA Advisory Board

Click here to read more


WELCOME to bigdna ltd

BigDNA Ltd is developing a patented DNA vaccine platform based upon the use of modified proprietary bacteriophages. This will allow rapid, cost effective manufacturing of vaccines, which are stable for ease of storage and transport.

INFORMATION FOR POTENTIAL INVESTORS

BigDNA is a well capitalised company and currently has a diverse, well structured investor portfolio to allow us to develop our platform vaccine technology through phase I trials.

PARTNERING INFORMATION

BigDNA has both a strong, focussed product development program built on key products and an active research arm, whose aim is to develop the core platform technology and to expand the range of vaccines delivered.

SCIENTIFIC INFORMATION

BigDNA actively seeks to work with academic and industrial partners who may be interested in research and development using our novel platform.